Related Experiment Video
Updated: Jun 28, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Correlation between hepatitis B genotypes, 1896 precore mutation, virus loads and liver dysfunction in an Indian
Perumal Vivekanandan1, Sara Bissett, Samreen Ijaz
1Department of Clinical Virology, Christian Medical College, Vellore, India.
Hepatitis B virus (HBV) genotype C is linked to higher viral loads and may be more pathogenic. The 1896 precore mutation did not correlate with HBV DNA levels in this study.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Hepatitis B virus (HBV) genotypes exhibit varying pathogenicity.
- The interaction between HBV genotypes, mutations, and viral loads is not fully understood.
- Investigating these factors is crucial for understanding HBV-related liver disease progression.
Purpose of the Study:
- To examine the association between HBV genotype, the 1896 precore mutation, and HBV viral loads.
- To determine the correlation between these viral characteristics and liver disease markers like ALT levels.
Main Methods:
- Recruitment of 116 HBV DNA-seropositive patients and 107 HBV DNA-seropositive blood donors.
- Stratification of subjects into groups with normal (Group I) and elevated (Group II) ALT levels.
- Determination of HBV genotype, 1896 precore mutation presence, and plasma HBV DNA levels.
Main Results:
- Genotype C was significantly more prevalent in patients with elevated ALT (Group II) compared to those with normal ALT (Group I).
- No correlation was found between the 1896 precore mutation and HBV DNA levels.
- Subjects infected with genotype C exhibited higher HBV DNA levels than those with genotypes A or D.
Conclusions:
- HBV genotype, specifically genotype C, correlates with higher viral loads and elevated ALT levels, suggesting increased pathogenicity.
- The 1896 precore mutation does not appear to be a significant factor in determining HBV viral load.
- Genotype C's association with higher virus loads and liver enzyme elevation warrants further investigation into its clinical significance.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
